ECMO在儿童器官移植中的应用进展

焦国慧, 陈静瑜, 苗晶晶, 王玉姬, 骆庆峰

焦国慧, 陈静瑜, 苗晶晶, 王玉姬, 骆庆峰. ECMO在儿童器官移植中的应用进展[J]. 协和医学杂志. DOI: 10.12290/xhyxzz.2024-0752
引用本文: 焦国慧, 陈静瑜, 苗晶晶, 王玉姬, 骆庆峰. ECMO在儿童器官移植中的应用进展[J]. 协和医学杂志. DOI: 10.12290/xhyxzz.2024-0752
JIAO Guohui, CHEN Jingyu, MIAO Jingjing, WANG Yuji, LUO Qingfeng. Advancements in the Application of ECMO in Pediatric Organ Transplantation[J]. Medical Journal of Peking Union Medical College Hospital. DOI: 10.12290/xhyxzz.2024-0752
Citation: JIAO Guohui, CHEN Jingyu, MIAO Jingjing, WANG Yuji, LUO Qingfeng. Advancements in the Application of ECMO in Pediatric Organ Transplantation[J]. Medical Journal of Peking Union Medical College Hospital. DOI: 10.12290/xhyxzz.2024-0752

ECMO在儿童器官移植中的应用进展

基金项目: 

国家药品监督管理局体外循环器械重点实验室开放课题资金支持/资助(编号:2024YB01)

国家四大慢病重大专项:急性呼吸衰竭关键诊疗技术及慢性呼吸衰竭长期管理体系构建研究(编号2023YFC2507100)

详细信息
    通讯作者:

    王玉姬,E-mail:wangyj@cmde.org.cn

    骆庆峰,E-mail:luoqf@cmde.org.cn

  • 中图分类号: R617

Advancements in the Application of ECMO in Pediatric Organ Transplantation

Funds: 

National Medical Products Administration Key Laboratory for Extracorporeal Circulation Devices: Open Project (2024YB01)

Noncommunicable Chronic Diseases-National Science and Technology Major Project ( 2023YFC2507100)

  • 摘要: 器官移植作为治疗儿童终末期器官功能衰竭的手段,随着手术技术、器官保存技术和免疫抑制药物的发展,手术成功率和受者长期生存质量不断得到提升。体外膜肺氧合(ExtracorporealMembrane Oxygenation,ECMO)在儿童器官移植受者中的应用,早期以心肺移植为主,逐渐拓展到对肝、肾等腹腔脏器移植围术期发生的心肺并发症的支持,以及用于供体的维护过程。随着ECMO技术和器械的不断升级,其在儿童终末期器官衰竭的支持治疗中地位越来越显著,让更多的器官功能衰竭儿童重获新生。
    Abstract: Organ transplantation, as a therapeutic option for children with end-stage organ failure, has seen continuous improvement in surgical techniques, organ preservation methods, and immunosuppressive drugs, leading to enhanced surgical success rates and long-term quality of life for recipients. Initially focused on heart and lung transplants in pediatric recipients, extracorporeal membrane oxygenation (ECMO) application has expanded to provide support for cardiopulmonary complications occurring during abdominal organ transplants such as liver and kidney, as well as for the maintenance of donor organs. With the ongoing advancements in ECMO technology and equipment, its significance in supporting therapy for end-stage organ failure in children is becoming increasingly prominent, granting a new lease on life to more children facing organ failure.
  • [1]

    Bianzina S, Singh Y, Iacobelli R, et al. Use of point-of-care ultrasound (POCUS) to monitor neonatal and pediatric extracorporeal life support [J]. Eur J Pediatr, 2024, 183(4):1509-1524.

    [2]

    Reid TD, Kratzke I, Dayal D, et al. The role of extracorporeal membrane oxygenation in pediatric abdominal transplant patients: A qualitative systematic review of literature [J]. Pediatr Transplant, 2021, 25(3):e13939.

    [3]

    Valencia E, Nasr VG. Updates in Pediatric Extracorporeal Membrane Oxygenation [J]. J Cardiothorac Vasc Anesth, 2020, 34(5):1309-1323.

    [4]

    Di Nardo M, Ahmad AH, Merli P, et al. Extracorporeal membrane oxygenation in children receiving haematopoietic cell transplantation and immune effector cell therapy: an international and multidisciplinary consensus statement [J]. Lancet Child Adolesc Health, 2022, 6(2):116- 128.

    [5]

    Ohsumi A, Date H. Perioperative circulatory support for lung transplantation [J]. Gen Thorac Cardiovasc Surg, 2021, 69(4):631-637.

    [6]

    Sakurai K, Singhal N. Extracorporeal membrane oxygenation in children: A brief review [J]. J Paediatr Child Health, 2022, 58(9):1525-1531.

    [7] 儿童体外膜氧合专家共识撰写组,中华医学会儿科学分会急救学组. 体外膜氧合在儿童危重症应用的专家共识[J]. 中华儿科杂志, 2022,60(3):183-191.

    Expert Consensus Writing Group on Pediatric Extracorporeal Membrane Oxygenation, Emergency Medicine Group of the Chinese Pediatric Society, Chinese Medical Association. Expert consensus on the application of extracorporeal membrane oxygenation in critically ill children[J]. Chinese Journal of Pediatrics, 2022, 60(3): 183-191.

    [8]

    Kirshbom PM, Bridges ND, Myung RJ, et al. Use of extracorporeal membrane oxygenation in pediatric thoracic organ transplantation[J]. J Thorac Cardiovasc Surg, 2002, 123(1):130-136.

    [9]

    Azoulay E, Russell L, Van de Louw A, et al. Diagnosis of severe respiratory infections in immunocompromised patients[J]. Intensive Care Med, 2020, 46(2):298-314.

    [10]

    An HY, Kang HJ, Park JD. Outcomes of extracorporeal membrane oxygenation support in pediatric hemato-oncology patients[J]. Acute Crit Care, 2024, 39(1):108-116.

    [11]

    Mowrer MC, Lima L, Nair R, et al. Pediatric Hematology and Oncology Patients on Extracorporeal Membrane Oxygenation: Outcomes in a Multicenter, Retrospective Cohort, 2009-2021[J]. Pediatr Crit Care Med, 2024, 25(11):1026-1034.

    [12]

    Zhang Z, Ding H, Liu F, et al. Successful bilateral lung transplantation and simultaneous Nuss technique correction of pectus excavatum post-allogeneic haematopoietic stem cell transplantation[J]. Interact Cardiovasc Thorac Surg, 2020, 30(2):319-320.

    [13]

    Gajkowski EF, Herrera G, Hatton L, et al. ELSO Guidelines for Adult and Pediatric Extracorporeal Membrane Oxygenation Circuits[J]. ASAIO J, 2022, 68(2):133-152.

    [14]

    Su JA, Kelly RB, Grogan T, et al. Extracorporeal membrane oxygenation support after pediatric orthotopic heart transplantation[J]. Pediatr Transplant, 2015, 19(1):68-75.

    [15]

    Bearl DW, Jeewa A, Auerbach SR, et al. Clinical approach to mechanical circulatory support in the transplant patient from the Pediatric Heart Transplant Society[J]. Pediatr Transplant, 2022, 26(8):e14391.

    [16] 蔡子文,张泰隆,王寅,等. ECMO在儿童心脏移植中的应用. 器官移植, 2023, 14(01):49-55 Cai ZW, Zhang TL, Wang Y, et al. Application of ECMO in pediatric heart transplantation [J]. Organ Transplantation, 2023, 14(01): 49-55.
    [17]

    Raymundo S, Wilhalme H, Chaudhary A, et al. Pediatric risk to orthotopic heart transplant (PRO) score: Insights from United Network for Organ Sharing (UNOS) waitlist mortality findings[J]. Pediatr Transplant, 2023, 27(6):e14525.

    [18]

    Gupta D, Bansal N, Jaeger BC, et al. Prolonged hospital length of stay after pediatric heart transplantation: A machine learning and logistic regression predictive model from the Pediatric Heart Transplant Society[J]. J Heart Lung Transplant, 2022, 41(9):1248-1257.

    [19]

    Jeung MS, Kim MJ, Huh J, et al. The Waiting List Mortality of Pediatric Heart Transplantation Candidates in Korea before the Pediatric Ventricular Assist Device Era[J]. J Korean Med Sci, 2021, 36(44):e283.

    [20]

    Godown J, Bearl DW, Thurm C, et al. Extracorporeal membrane oxygenation use in the first 24 hours following pediatric heart transplantation: Incidence, risk factors, and outcomes[J]. Pediatr Transplant, 2019, 23(4):e13414.

    [21]

    Wu WK, Siegrist KK, Ziogas IA, et al. Perioperative Characteristics and Outcomes of Fontan Versus Non-Fontan Patients Undergoing Combined Heart-Liver Transplantation: A Retrospective Cohort Study[J]. J Cardiothorac Vasc Anesth, 2024, 38(3):745-754.

    [22]

    Nair AG, Sleeper LA, Smoot LB, et al. Extracorporeal Membrane Oxygenation Support After Heart Transplantation in Children-Outcomes of a Single Center Cohort[J]. Pediatr Crit Care Med, 2020, 21(4):332-339.

    [23]

    Auerbach SR, Arshad A, Azeka E, et al. Impact of prolonged ischemic time on pediatric heart transplantation outcomes: Improved outcomes in the most recent era[J]. J Heart Lung Transplant, 2024, 43(7):1142-1152.

    [24]

    Masotti ES, Morrison JM, Fierstein JL, et al. Optimal Donor Allograft Function: The Search for the Lowest Acceptable Donor Left Ventricular Ejection Fraction in Pediatric Heart Transplantation[J]. Transplantation, 2023, 107(7):1554-1563.

    [25]

    Wen S, Zhou Y, Qiao W, et al. Infant heart transplantation with extremely oversized donor heart: is the donor-recipient size matching too conservative[J]? ESC Heart Fail, 2023, 10(2):1431- 1434.

    [26]

    Miana LA, Silva G, Caneo LF, et al. Rational Use of Mechanical Circulatory Support as a Bridge to Pediatric and Congenital Heart Transplantation[J]. Braz J Cardiovasc Surg, 2018, 33(3):242- 249.

    [27]

    Colvin MM, Smith JM, Ahn YS, et al. OPTN/SRTR 2021 Annual Data Report: Heart[J]. Am J Transplant, 2023, 23(2 Suppl 1):S300-S378.

    [28]

    Peer SM, Koehl DA, Cantor RS, et al. Effect of preoperative extracorporeal membrane oxygenation therapy on postventricular assist device outcomes: an analysis of the STS Pedimacs database[J]. Eur J Cardiothorac Surg, 2022, 62(6).

    [29]

    Das BB, Trivedi J, Deshpande SR, et al. Recent Era Outcomes of Mechanical Circulatory Support in Children With Congenital Heart Disease as a Bridge to Heart Transplantation[J]. ASAIO J, 2022, 68(3):432-439.

    [30]

    Bermudez CA, McMullan DM. Extracorporeal life support in preoperative and postoperative heart transplant management[J]. Ann Transl Med, 2017, 5(20):398.

    [31]

    Conway J, Cantor R, Koehl D, et al. Survival After Heart Transplant Listing for Infants on Mechanical Circulatory Support[J]. J Am Heart Assoc, 2020, 9(21):e011890.

    [32]

    Frandsen EL, Banker KA, Mazor RL, et al. Waitlist and posttransplant outcomes of critically ill infants awaiting heart transplantation managed without ventricular assist device support[J].Pediatr Transplant, 2022, 26(6):e14308.

    [33]

    Townsend ML, Sadat-Hossieny S, Latifi SQ, et al. Temporary Veno-Venous ECMO for Acute Respiratory Illness in Pediatric Berlin Heart Patient[J]. World J Pediatr Congenit Heart Surg, 2022, 13(4):510-511.

    [34]

    Valapour M, Lehr CJ, Schladt DP, et al. OPTN/SRTR 2022 Annual Data Report: Lung[J]. Am J Transplant, 2024, 24(2S1):S394-S456.

    [35]

    Carvajal HG, Merritt TC, Canter MW, et al. Improved Outcomes of Infant Lung Transplantation Over 3 Decades[J]. Ann Thorac Surg, 2022, 114(1):184-192.

    [36]

    Nelson JS, Maul TM, Aughtman SL, et al. A shifting landscape: Practice patterns and outcomes of cystic fibrosis and non-cystic fibrosis pediatric lung transplantation. Pediatr Transplant 2021, 25(7):e14086.

    [37]

    Himebauch AS, Yehya N, Schaubel DE, et al. Poor functional status at the time of waitlist for pediatric lung transplant is associated with worse pretransplant outcomes[J]. J Heart Lung Transplant, 2023, 42(12):1735-1742.

    [38]

    Iablonskii P, Carlens J, Mueller C, et al. Indications and outcome after lung transplantation in children under 12 years of age: A 16-year single center experience[J]. J Heart Lung Transplant, 2022, 41(2):226-236.

    [39]

    Koh W, Zang H, Ollberding NJ, et al. Extracorporeal membrane oxygenation bridge to pediatric lung transplantation: Modern era analysis[J]. Pediatr Transplant, 2023, 27(6):e14570.

    [40]

    Ahmed HF, Morales DLS, Hayes D, Jr. ECMO Bridge to Lung Transplant in Children with Idiopathic Pulmonary Arterial Hypertension[J]. Lung, 2024. 2024, 202(5):753-755.

    [41]

    Thompson K, Staffa SJ, Nasr VG, et al. Mortality after Lung Transplantation for Children Bridged with Extracorporeal Membrane Oxygenation[J]. Ann Am Thorac Soc, 2022, 19(3):415- 423.

    [42]

    Chiel LE, Winthrop ZA, Fynn-Thompson F, et al. Extracorporeal membrane oxygenation and paracorporeal lung assist devices as a bridge to pediatric lung transplantation[J]. Pediatr Transplant, 2022, 26(5):e14289.

    [43]

    Skansebo E, Broome M, Magnusson J, et al. Extended use of extra corporeal membrane oxygenation as bridge to lung transplantation in two patients[J]. J Cardiothorac Surg, 2020, 15(1):16.

    [44]

    Sommer W, Warnecke G. Lung transplantation for pediatric pulmonary arterial hypertensionquo vadis[J]? Cardiovasc Diagn Ther, 2021, 11(4):1178-1189.

    [45]

    Jack T, Carlens J, Diekmann F, et al. Bilateral lung transplantation for pediatric pulmonary arterial hypertension: perioperative management and one-year follow-up[J]. Front Cardiovasc Med, 2023, 10:1193326.

    [46]

    Yue B, Wu B, Zhang J, et al. Pediatric lung transplantation in the largest lung transplantation center of China: embarking on a long road[J]. Sci Rep, 2020, 10(1):12471.

    [47]

    Halpern AL, Kohtz PD, Helmkamp L, et al. Improved Mortality Associated With the Use of Extracorporeal Membrane Oxygenation[J]. Ann Thorac Surg, 2019, 108(2):350-357.

    [48]

    Sainathan S, Ryan J, Sharma M, et al. Outcome of Bridge to Lung Transplantation With Extracorporeal Membrane Oxygenation in Pediatric Patients 12 Years and Older[J]. Ann Thorac Surg, 2021, 112(4):1083-1088.

    [49]

    Stephens NA, Chartan CA, Gazzaneo MC, et al. Use of Berlin EXCOR cannulas in both venovenous and venoarterial central extracorporeal membrane oxygenation configurationsovercomes the problem of cannula instability while bridging infants and young children to lung transplant[J]. JTCVS Tech, 2023, 18:111-120.

    [50]

    Herrera-Camino A, Sweet SC, Pendino R, et al. Lung Re-transplantation after prolonged venovenous extracorporeal membrane oxygenation (ECMO) in a child with chronic lung allograft dysfunction[J]. Pediatr Transplant, 2024, 28(1):e14579.

    [51]

    Jean S, Chardot C, Oualha M, et al. Extracorporeal Membrane Oxygenation Can Save Lives in Children With Heart or Lung Failure After Liver Transplantation[J]. Artif Organs, 2017, 41(9):862-865.

    [52]

    Di Nardo M, Cousin VL, Alunni-Fegatelli D, et al. Extracorporeal Membrane Oxygenation After Liver Transplant in Children: A Review of the ELSO Registry[J]. ASAIO J, 2024, 70(7):621-624.

    [53]

    Ziogas IA, Johnson WR, Matsuoka LK, et al. Extracorporeal Membrane Oxygenation in Pediatric Liver Transplantation: A Multicenter Linked Database Analysis and Systematic Review of the Literature[J]. Transplantation, 2021, 105(7):1539-1547.

    [54]

    Sanchez Perez B, Perez Reyes M, Aranda Narvaez J, et al. New therapeutic strategy with extracorporeal membrane oxygenation for refractory hepatopulmonary syndrome after liver transplant: A case report[J]. World J Transplant, 2024, 14(1):89223.

    [55]

    Wu WK, Grogan WM, Ziogas IA, et al. Extracorporeal membrane oxygenation in patients with hepatopulmonary syndrome undergoing liver transplantation: A systematic review of the literature[J]. Transplant Rev (Orlando), 2022, 36(2):100693.

    [56]

    Huang J, Yoeli D, Sundaram SS, et al. Extracorporeal membrane oxygenation as rescue therapy in a pediatric liver transplant recipient with very severe hepatopulmonary syndrome[J]. Pediatr Transplant, 2022, 26(2):e14185.

    [57]

    Scott JP, Hong JC, Thompson NE, et al. Central ECMO for circulatory failure following pediatric liver transplantation[J]. Perfusion, 2018, 33(8):704-706.

    [58]

    Shimura K, Matsumoto S, Ide K, et al. Rescue venovenous extracorporeal membrane oxygenation for the deterioration of acute respiratory distress syndrome in pediatric liver transplantation[J]. Pediatr Transplant, 2022, 26(6):e14305.

    [59]

    Phillips MR, Priest M, Beaty C, et al. Extracorporeal Membrane Oxygenation in a Pediatric Patient with Hepatopulmonary Syndrome and Interrupted Inferior Vena Cava After Living Related Liver Donation[J]. ASAIO J, 2019, 65(3):e27-e29.

    [60]

    Short K, McBride M, Anderson S, et al. Survival of Infants With Severe Congenital Kidney Disease After ECMO and Kidney Support Therapy[J]. Pediatrics, 2024, 153(3).

    [61]

    Rybalko A, Pytal A, Kaabak M, et al. Case Report: Successful Use of Extracorporeal Therapies After ECMO Resuscitation in a Pediatric Kidney Transplant Recipient[J]. Front Pediatr, 2020, 8:593123.

    [62]

    Jiao G, Wang Y, Guan Y, et al. Regulatory challenges in innovation and evaluation of extracorporeal membrane oxygenation: Database analysis and future perspectives[J]. Chin Med J (Engl), 2024.

    [63]

    Fujita S, Ushijima T, Shinohara G, et al. Veno-venous extracorporeal membrane oxygenation support of pulmonary insufficiency using Avalon Elite((R)) cannula in pediatric patients[J]. J Artif Organs 2024, 27(3):301-305.

    [64]

    Vijayakumar N, Badheka A, Chegondi M, et al. Successful use of Protek Duo cannula to provide veno-venous extra-corporeal membrane oxygenation and right ventricular support for acuterespiratory distress syndrome in an adolescent with complex congenital heart disease[J]. Perfusion, 2021, 36(2):200-203.

    [65] 郭佳莹,周滋晶,李耀华. 中美两国儿科用医疗器械监管现状及临床研究探讨[J]. 临床儿科杂志, 2024, 42(09):822-826 Guo JY, Zhou ZJ, Li YH. Current status of medical device regulation in pediatric healthcare in China and the United States: A clinical research exploration[J]. J Clin Pediatr, 2024, 42(09): 822-826.
    [66] 刘露,崔馨月,张宇晶,等. 成人数据外推至儿科人群探讨[J]. 中国医疗器械杂志, 2019, 43(05):375-378 Liu L, Cui XY, Zhang YJ, et al. Extrapolation of adult data to the pediatric population: A discussion[J]. Chinese Journal of Medical Instrumentation, 2019, 43(05): 375-378.
    [67]

    Espinoza J, Shah P, Nagendra G, et al. Pediatric Medical Device Development and Regulation: Current State, Barriers, and Opportunities[J]. Pediatrics, 2022, 149(5).

计量
  • 文章访问数:  76
  • HTML全文浏览量:  0
  • PDF下载量:  0
  • 被引次数: 0
出版历程
  • 网络出版日期:  2024-12-31

目录

    /

    返回文章
    返回
    x 关闭 永久关闭